Bio Pharma Dive
JANUARY 30, 2025
Despite high demand for an option like Journavx, doctors fear the drug’s price could be a major hangup for insurers, potentially limiting patients’ ability to access it.
Pharmaceutical Technology
JANUARY 30, 2025
The pathway allows medicine developers to work with the regulators, the NHS and health technology assessment bodies.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
JANUARY 30, 2025
The testing company ended last year with $79 million and told investors it will need to raise money to fund its operations and financial commitments.
Pharmaceutical Technology
JANUARY 30, 2025
Takeda has announced the appointment of Julie Kim as the successor to Christophe Weber, effective from June 2026.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Bio Pharma Dive
JANUARY 30, 2025
Robert F. Kennedy Jr., nominated to be health secretary, seemed unfamiliar with the particulars of the massive insurance program he'd oversee in exchanges with senators Thursday.
Pharmaceutical Technology
JANUARY 30, 2025
Leveragen has announced a strategic partnership with Moonlight Bio, targeting the development of T-cell therapies for challenging cancers.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Pharmaceutical Technology
JANUARY 30, 2025
Acellera and Psivant have announced a strategic research partnership aimed at developing computational drug discovery approaches.
Bio Pharma Dive
JANUARY 30, 2025
Julie Kim, currently Takeda’s U.S. head, will replace Weber in June 2026 and become one of the few female CEOs of a top drugmaker.
FDA Law Blog
JANUARY 30, 2025
By Mark A. Tobolowsky & Charles G. Raver & James E. Valentine We recently blogged about a new December 2024 draft guidance about accelerated approval (the December 2024 draft guidance). That post largely focused on endpoints as well as the broader context for when accelerated approval is appropriate. However, as we note in that post, the design, timing of initiation, and timely conduct of confirmatory trials are also important considerations in FDAs determination of whether accelerated
Bio Pharma Dive
JANUARY 30, 2025
Safety concerns and disappointing efficacy results have led Cargo to stop testing the treatment, cut 50% of its workforce and evaluate strategic alternatives.
Rethinking Clinical Trials
JANUARY 30, 2025
Speaker Jeffrey H. Samet, MD, MA, MPH John Noble Professor in General Internal Medicine & Professor of Public Health Boston University Chobanian and Avedisian School of Medicine and School of Public Health Boston Medical Center Slides Keywords Opioid Epidemic; Evidence-Based Practices; NIH HEAL Initiative; MOUD; OEND; Harm Reduction Key Points Over roughly 20 years, opioid overdose (OD) mortality in the U.S. increased tenfold: from a little over 8,000 in 1999 to over
pharmaphorum
JANUARY 30, 2025
Stay ahead of the curve by exploring the key trends shaping pharmaceutical operations in 2025, including cybersecurity, efficiency, workforce management, and technology advancements. Learn more about these important industry developments.
Drug Patent Watch
JANUARY 30, 2025
Maximizing Patent Protection: Strategies for Pharmaceutical Marketers As a pharmaceutical marketer, you know how crucial it is to protect your patented drug's market share. But with the ever-changing landscape of the industry, it can be challenging to stay ahead of the competition. In this post, we'll explore effective strategies for maximizing patent protection and exclusivity, ensuring your product remains a leader in the market.
pharmaphorum
JANUARY 30, 2025
UK Biobank study suggests someone's risk of premature ageing or cognitive decline could be predicted using a simple ECG reading supported by an AI
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Velocity Clinical Research
JANUARY 30, 2025
Velocity Clinical Research, the leading multi-specialty clinical research organization, has partnered with Verified Clinical Trials (VCT) to set a new benchmark for patient safety and data quality in clinical trials through a new technological implementation at Velocitys 80+ global sites. The collaboration addresses a critical industry challenge: the double enrollment of participants in multiple studies simultaneously across all clinical sites.
XTalks
JANUARY 30, 2025
In 2020, the US Food and Drug Administration (FDA) issued a Guidance for Industry recommending that sponsors include plans for developing age-appropriate formulations of drug products in instances where adult formulations may not be suitable for paediatric patients. In many cases, this guidance translates to a seemingly simple solution: for children, liquid formulations are often the preferred approach.
Intouch Solutions
JANUARY 30, 2025
In a recently published article from Med Ad News , co-authors Iyiola Obayomi, SVP, Managing Director, Data & Analytics, at EVERSANA INTOUCH, and Pierantonio Russo, MD, FCPP, FAAP, STS, Chief Medical Officer at EVERSANA, discuss the power of data and analytics and machine learning (ML) to optimize HCP targeting and prescription volume. In an era where AI and ML in healthcare are driving significant prescription gains by engaging healthcare professionals (HCPs) more effectively, success now de
pharmaphorum
JANUARY 30, 2025
ALK-Abello's Acarizax for dust mite allergy should soon be available through the NHS in England, Wales, and Northern Ireland, but not in Scotland.
Pharmaceutical Commerce
JANUARY 30, 2025
The latest news for pharma industry insiders.
pharmaphorum
JANUARY 30, 2025
Takeda's long-serving chief executive Christophe Weber has said he will retire next year, after 12 years at the Japanese drugmaker.
Outsourcing Pharma
JANUARY 30, 2025
Lantheus is acquiring radiopharmaceutical CDMO Evergreen Theragnostics in a deal worth up to $1 billion, expanding its manufacturing capabilities and drug pipeline. The acquisition includes Octevy, a PET imaging agent for neuroendocrine tumors, pending FDA approval.
pharmaphorum
JANUARY 30, 2025
Discover valuable insights into the rare disease landscape in Part 6 of our Life Sciences Industry Report. This white paper provides in-depth analysis and key findings for industry professionals.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Pharmaceutical Commerce
JANUARY 30, 2025
Can monitoring these dispensed Rxs via online search behavior help predict future GLP-1 use in the United States?
pharmaphorum
JANUARY 30, 2025
HCP marketings Pharma 4.0 moment: Leveraging AI for real-time campaign optimisation Mike.
BioPharma Reporter
JANUARY 30, 2025
Inhibikase Therapeutics announced disappointing results from a Phase 2 trial for its Parkinsons disease drug, risvodetinib, and will now pause its development.
pharmaphorum
JANUARY 30, 2025
Explore effective health strategies and initiatives aimed at combatting misinformation in men's healthcare, particularly in the realm of mental health.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Pharmaceutical Commerce
JANUARY 30, 2025
How pharmaceutical manufacturers should consider their Fair Market Value cost assessment compared to their negotiation leverage when contracting for distribution services
pharmaphorum
JANUARY 30, 2025
Join us at the 3rd Precision Medicine in Inflammatory Bowel Disease Summit on May 13-15, 2025, organised by Hanson Wade. This event will bring together experts to discuss the latest advancements in precision medicine for IBD.
Pharmaceutical Commerce
JANUARY 30, 2025
In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, value & access advisor for Schoonveld Advisory and author of The Price of Global Health, comments on the future implications of the latest CMS drug price negotiations.
pharmaphorum
JANUARY 30, 2025
In a new pharmaphorum podcast with ZS Associates Sharon Karlsberg, principal and leader of oncology solutions, and Brandi Davis-Dusenbery, principal and partner, web editor Nicole Raleigh explores the potential for scaling advanced technologies in the biopharmaceutical industry.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Expert insights. Personalized for you.
359 
Let's personalize your content